Sexual Function Impaired Less With Nerve-sparing Surgery in Cervical Cancer

Share this content:
Sexual Function Impaired Less With Nerve-sparing Surgery in Cervical Cancer
Sexual Function Impaired Less With Nerve-sparing Surgery in Cervical Cancer

Nerve-sparing (NS) laparoscopic radical hysterectomy (LRH) impairs sexual function less than conventional LRH in cervical cancer patients, according to a study published in the Journal of Sexual Medicine.

Giorgio Bogani, MD, from the University of Insubria in Varese, Italy, and colleagues evaluated sexually active cervical cancer patients undergoing type C (class III) LRH (2004 to 2013). The authors sought to determine the impact of NS procedures on preoperative versus postoperative sexual function.

The researchers found that, of the 40 patients undergoing radical hysterectomy (20 conventional LRH vs. 20 NS-LRH), there were no differences in preoperative Female Sexual Function Index (FSFI) scores (P>0.05).

While postoperative FSFI scores were worse in both groups (P<0.001), patients undergoing NS-LRH had higher postoperative FSFI scores than patients undergoing conventional LRH (21.3 vs. 14.2; P=0.04).

Specific postoperative domain scores showed that desire, arousal, orgasm and pain scores were similar between groups (P>0.05), while patients undergoing NS-LRH experienced higher lubrication (3.4 vs. 1.7; P=0.02) and satisfaction (4.6 vs. 2.8; P=0.004) scores, compared to patients undergoing conventional LRH.

Survival outcomes were similar between the groups.

"The NS approach impairs sexual function less, minimizing the effects of radical surgery," the researchers wrote.

Reference

  1. Bogani G et al. J Sex Med. 2014;doi:10.1111/jsm.12702.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters